When metformin is not enough: Pros and cons of SGLT2 and DPP-4 inhibitors as a second line therapy

Angelo Avogaro, Elías Delgado, Ildiko Lingvay

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'When metformin is not enough: Pros and cons of SGLT2 and DPP-4 inhibitors as a second line therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences